المؤلفون: Bajaj, K., Vora, D.N., Parab, P., Shaikh, H., Gulia, S., Rath, S., Bajpai, J., Shet, T., Desai, S., Popat, P., Rajan, R., Nair, N.S., Joshi, S., Pathak, R., Sarin, R., Kembhavi, Y., Rane, S., Ghosh, J., Badwe, R.A., Gupta, S.

المصدر: Annals of Oncology ; volume 33, page S1439 ; ISSN 0923-7534

الاتاحة: http://dx.doi.org/10.1016/j.annonc.2022.10.032
https://api.elsevier.com/content/article/PII:S0923753422042235?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0923753422042235?httpAccept=text/plain

المؤلفون: Bajpai, J., Kagwade, S., Chandrasekharan, A., Dandekar, S., Kanan, S., Kembhavi, Y., Ghosh, J., Banavali, S.D., Gupta, S.

المساهمون: Breast disease management group and department of medical oncology

المصدر: The Breast ; volume 49, page 187-193 ; ISSN 0960-9776

الاتاحة: http://dx.doi.org/10.1016/j.breast.2019.12.004
https://api.elsevier.com/content/article/PII:S0960977619311117?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0960977619311117?httpAccept=text/plain

المؤلفون: Shah, M.J., Rath, S., Gulia, S., Bhargava, P.G., Sekar, A., Bajpai, J., Shet, T., Desai, S., Sarin, R., Pathak, R., Popat, P., Parab, P., Kembhavi, Y., Patil, A., Nair, N.S., Rane, P., Joshi, S., Badwe, R.A., Gupta, S.

المصدر: Annals of Oncology ; volume 34, page S1483 ; ISSN 0923-7534

الاتاحة: http://dx.doi.org/10.1016/j.annonc.2023.10.180
https://api.elsevier.com/content/article/PII:S0923753423043867?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0923753423043867?httpAccept=text/plain

المؤلفون: Gupta, S., Parab, P., Kerkar, R., Mahantshetty, U., Maheshwari, A., Sastri, S., Engineer, R., Hawaldar, R., Ghosh, J., Gulia, S., Godbole, S., Kumar, N., Malliga, J., Dalvi, R., Kembhavi, Y., Gaikar, M., Ranade, R., Tongaonkar, H., Badwe, R., Shrivastava, S.

المصدر: Annals of Oncology ; volume 28, page v627 ; ISSN 0923-7534

الاتاحة: http://dx.doi.org/10.1093/annonc/mdx440.038
https://api.elsevier.com/content/article/PII:S0923753420391389?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0923753420391389?httpAccept=text/plain
http://academic.oup.com/annonc/article-pdf/28/suppl_5/mdx440.038/19941862/mdx440.038.pdf

المؤلفون: Gupta, S, Sahu, A, Godbole, S, Jain, P, Ghosh, J, Shrikhande, S, Ramadwar, M, Goyal, M, Gulia, S, Bajpai, J, Kembhavi, Y

المصدر: Indian Journal of Cancer ; volume 52, issue 3, page 320 ; ISSN 0019-509X

الاتاحة: https://doi.org/10.4103/0019-509x.176747

المؤلفون: Sahu, A., Godbole, S., Jain, P., Ghosh, J., Shrikhande, S., Ramadwar, M., Goyal, M., Gulia, S., Bajpai, J., Kembhavi, Y., Gupta, S.

المصدر: Indian Journal of Cancer; Jul-Sep2015, Vol. 52 Issue 3, p320-323, 4p

مصطلحات موضوعية: DRUG therapy, IMATINIB, GASTROINTESTINAL stromal tumors, DRUG resistance, DRUG efficacy, DRUG dosage, TUMOR treatment, ANTINEOPLASTIC agents, HETEROCYCLIC compounds, LONGITUDINAL method, PROGNOSIS, RESEARCH funding, GASTROINTESTINAL tumors, TREATMENT effectiveness, DISEASE progression, INDOLE compounds, THERAPEUTICS